Great work Alex. I've just noticed that Edward Mills is the supervising author for this study but works for Cytel. He declares this on his form, and also his funding from the BMGF. But he doesn't declare his collaboration with Kristian Thorlund and Kyle Sheldrick in the pseudo-attack on molnupiravir (https://pubmed.ncbi.nlm.nih.gov/35294804/). At the same time the conflict form includes two dates of submission - 21st Nov 2021 and 24th Feb 2022. This happens if there have been late additions to the authorship, after it was first submitted. The additional authorship relates to Craig Rayner who appears to be the late arrival and has multiple conflicts including Pfizer and the Australian government. The conflicts document is here (https://www.nejm.org/doi/suppl/10.1056/NEJMoa2115869/suppl_file/nejmoa2115869_disclosures.pdf). He is the founder of Certara, an organisation that is putatively involved in finding repurposed drugs. I would hazard a guess that the only repurposed drugs they have found for anything would be very expensive patented drugs, but that would be cynical. The whole thing stinks
We use necessary cookies to make our site work. We also set performance and functionality cookies that help us make
improvements by measuring traffic on our site. For more detailed information about the cookies we use, please see our
privacy policy.
✖
The Problem with the TOGETHER Trial
Great work Alex. I've just noticed that Edward Mills is the supervising author for this study but works for Cytel. He declares this on his form, and also his funding from the BMGF. But he doesn't declare his collaboration with Kristian Thorlund and Kyle Sheldrick in the pseudo-attack on molnupiravir (https://pubmed.ncbi.nlm.nih.gov/35294804/). At the same time the conflict form includes two dates of submission - 21st Nov 2021 and 24th Feb 2022. This happens if there have been late additions to the authorship, after it was first submitted. The additional authorship relates to Craig Rayner who appears to be the late arrival and has multiple conflicts including Pfizer and the Australian government. The conflicts document is here (https://www.nejm.org/doi/suppl/10.1056/NEJMoa2115869/suppl_file/nejmoa2115869_disclosures.pdf). He is the founder of Certara, an organisation that is putatively involved in finding repurposed drugs. I would hazard a guess that the only repurposed drugs they have found for anything would be very expensive patented drugs, but that would be cynical. The whole thing stinks